Erratum

Errata

This article corrects:

  1. First interim analysis of the GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib) non-interventional study Volume 66, Issue 7, 675–683, Article first published online: 15 June 2012

Original paper “First interim analysis of the GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib) non-interventional study”. Int J Clin Pract 2012; 66: 675–683.

A co-author’s name was incorrectly printed as L.L de Guevara. The correct name is L. Ladrón de Guevara.

Also, in the results section, under sorafenib administration by Child-Pugh status, the sentence “Duration of treatment was generally shorter in Child-Pugh A than in Child-Pugh B patients.” should read “Duration of treatment was generally shorter in Child-Pugh B than in Child-Pugh A patients.”

All other data in the paragraph, in the relevant table and the remainder of the paragraph are correct.

Ancillary